 | Up a level |
Bagnoud, Maud; Remlinger, Jana; Joly, Sandrine; Massy, Marine; Salmen, Anke; Chan, Andrew; Karathanassis, Dimitris; Evangelopoulos, Maria-Eleptheria; Hoepner, Robert (2024). Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis. CNS neuroscience & therapeutics, 30(2), e14484. Wiley 10.1111/cns.14484
Remlinger, Jana; Bagnoud, Maud; Meli, Ivo; Massy, Marine; Linington, Christopher; Chan, Andrew; Bennett, Jeffrey L; Hoepner, Robert; Enzmann, Volker; Salmen, Anke (2023). Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations. Multiple Sclerosis and Related Disorders, 78(104892), p. 104892. Elsevier 10.1016/j.msard.2023.104892
Bagnoud, Maud; Remlinger, Jana; Massy, Marine; Lodygin, Dmitri; Salmen, Anke; Chan, Andrew; Lühder, Fred; Hoepner, Robert (2023). In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling. Cells, 12(18) MDPI 10.3390/cells12182291
Remlinger, Jana; Bagnoud, Maud; Meli, Ivo; Massy, Marine; Hoepner, Robert; Linington, Christopher; Chan, Andrew; Bennett, Jeffrey L; Enzmann, Volker; Salmen, Anke (2023). Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations. Neurology: Neuroimmunology and Neuroinflammation, 10(5) Wolters Kluwer Health 10.1212/NXI.0000000000200141
Massy, Marine; Hoepner, Robert; Pistor, Maximilian (January 2024). Personalisierte MS-Therapie. Forte. Das Magazin der Schweizerischen Multiple Sklerose Gesellschaft(1), pp. 8-10.
